Ticker

NBIX

Name

Neurocrine Biosciences Inc

Price

Loading...

Sector

Health Care

17th Jan, 2021

Total Mark

91

Above 70 is preferred

Stock Analysis

Growth Potential
100
Profitability
88
Financial Strength
83
Q4 2019 Result
92
Q3 2019 Result
96
Result 2019
83

Growth Estimate

20 Estimate21 Estimate
Revenue Growth (%)36.627.6
EPS Growth (%)108.546.7
ROE (%)39.343.7
P/E (times)......

Market Analysis

Market Sentiment
33
Relative Valuation
98
Being a Value Stock
57
Absolute Valuation
NA

For more detailed information about Neurocrine Biosciences Inc, please go to Yahoo Finance